Feeder-independent derivation of induced-pluripotent stem cells from peripheral blood endothelial progenitor cells

Stem Cell Research

Volumn 10, Issue 2, 2013, Pages 195-202

  Chang, Wing Y ^a,b,e   Lavoie, Jessie R ^a,b   Kwon, Sarah Y ^a,c   Chen, Zhaoyi ^a,b   Manias, Janet L ^a,b   Behbahani, John ^a,b   Ling, Vicki ^a   Kandel, Rita A ^d   Stewart, Duncan J ^a,b   Stanford, William L ^a,b,c  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d MOUNT SINAI HOSPITAL   (Canada)

^e StemCell Technologies Inc   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

KRUPPEL LIKE FACTOR 4; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR SOX2;

ARTICLE; CELL CULTURE; CELL FUNCTION; EMBRYONIC STEM CELL; ENDOTHELIAL PROGENITOR CELL; HUMAN; HUMAN CELL; KARYOTYPE; PERIPHERAL BLOOD STEM CELL; PLURIPOTENT STEM CELL; PRIORITY JOURNAL;

BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL PROLIFERATION; EMBRYONIC STEM CELLS; ENDOTHELIAL CELLS; FEEDER CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; KARYOTYPING; NUCLEAR REPROGRAMMING; RETROVIRIDAE; TRANSCRIPTOME;

EID: 84872029640     PISSN: 18735061     EISSN: 18767753     Source Type: Journal    
DOI: 10.1016/j.scr.2012.11.006     Document Type: Article

References (27)

1. Brown M.E., Rondon E., Rajesh D., Mack A., Lewis R., Feng X., Zitur L.J., Learish R.D., Nuwaysir E.F. Derivation of induced pluripotent stem cells from human peripheral blood T lymphocytes. PLoS One 2010, 5:e11373.
2. Chang W.Y., Bryce D.M., D'Souza S.J., Dagnino L. The DP-1 transcription factor is required for keratinocyte growth and epidermal stratification. J. Biol. Chem. 2004, 279:51343-51353.
3. Chang W.Y., Garcha K., Manias J.L., Stanford W.L. Deciphering the complexities of human diseases and disorders by coupling induced-pluripotent stem cells and systems genetics. Wiley Interdiscip. Rev. Syst. Biol. Med. 2012, 4:339-350.
4. Chen G., Gulbranson D.R., Hou Z., Bolin J.M., Ruotti V., Probasco M.D., Smuga-Otto K., Howden S.E., Diol N.R., Propson N.E., et al. Chemically defined conditions for human iPSC derivation and culture. Nat. Methods 2011, 8:424-429.
5. Choi S.M., Liu H., Chaudhari P., Kim Y., Cheng L., Feng J., Sharkis S., Ye Z., Jang Y.Y. Reprogramming of EBV-immortalized B-lymphocyte cell lines into induced pluripotent stem cells. Blood 2011, 118:1801-1805.
6. Eminli S., Utikal J., Arnold K., Jaenisch R., Hochedlinger K. Reprogramming of neural progenitor cells into induced pluripotent stem cells in the absence of exogenous Sox2 expression. Stem Cells 2008, 26:2467-2474.
7. Grskovic M., Javaherian A., Strulovici B., Daley G.Q. Induced pluripotent stem cells-opportunities for disease modelling and drug discovery. Nat. Rev. Drug Discov. 2011, 10:915-929.
8. Ho P.J., Yen M.L., Lin J.D., Chen L.S., Hu H.I., Yeh C.K., Peng C.Y., Lin C.Y., Yet S.F., Yen B.L. Endogenous KLF4 expression in human fetal endothelial cells allows for reprogramming to pluripotency with just OCT3/4 and SOX2-brief report. Arterioscler. Thromb. Vasc. Biol. 2010, 30:1905-1907.
9. Hotta A., Cheung A.Y., Farra N., Garcha K., Chang W.Y., Pasceri P., Stanford W.L., Ellis J. EOS lentiviral vector selection system for human induced pluripotent stem cells. Nat. Protoc. 2009, 4:1828-1844.
10. Hotta A., Cheung A.Y., Farra N., Vijayaragavan K., Seguin C.A., Draper J.S., Pasceri P., Maksakova I.A., Mager D.L., Rossant J., et al. Isolation of human iPS cells using EOS lentiviral vectors to select for pluripotency. Nat. Methods 2009, 6:370-376.
11. Jodon de Villeroche V., Avouac J., Ponceau A., Ruiz B., Kahan A., Boileau C., Uzan G., Allanore Y. Enhanced late-outgrowth circulating endothelial progenitor cell levels in rheumatoid arthritis and correlation with disease activity. Arthritis Res. Ther. 2010, 12:R27.
12. Lasala G.P., Minguell J.J. Vascular disease and stem cell therapies. Br. Med. Bull. 2011, 98:187-197.
13. Lavoie J.R., Stewart D.J. Genetically modified endothelial progenitor cells in the therapy of cardiovascular disease and pulmonary hypertension. Curr. Vasc. Pharmacol. 2012, 10:289-299.
14. Lin Y., Weisdorf D.J., Solovey A., Hebbel R.P. Origins of circulating endothelial cells and endothelial outgrowth from blood. J. Clin. Invest. 2000, 105:71-77.
15. Lin R.Z., Dreyzin A., Aamodt K., Dudley A.C., Melero-Martin J.M. Functional endothelial progenitor cells from cryopreserved umbilical cord blood. Cell Transplant. 2011, 20:515-522.
16. Loh Y.H., Hartung O., Li H., Guo C., Sahalie J.M., Manos P.D., Urbach A., Heffner G.C., Grskovic M., Vigneault F., et al. Reprogramming of T cells from human peripheral blood. Cell Stem Cell 2010, 7:15-19.
17. Macarthur C.C., Fontes A., Ravinder N., Kuninger D., Kaur J., Bailey M., Taliana A., Vemuri M.C., Lieu P.T. Generation of human-induced pluripotent stem cells by a nonintegrating RNA sendai virus vector in feeder-free or xeno-free conditions. Stem Cells Int. 2012, 2012:564612.
18. Martin-Ramirez J., Hofman M., Van Den Biggelaar M., Hebbel R.P., Voorberg J. Establishment of outgrowth endothelial cells from peripheral blood. Nat. Protoc. 2012, 7:1709-1715.
19. Okita K., Matsumura Y., Sato Y., Okada A., Morizane A., Okamoto S., Hong H., Nakagawa M., Tanabe K., Tezuka K., et al. A more efficient method to generate integration-free human iPS cells. Nat. Methods 2011, 8:409-412.
20. O'Neill C.L., O'Doherty M.T., Wilson S.E., Rana A.A., Hirst C.E., Stitt A.W., Medina R.J. Therapeutic revascularisation of ischaemic tissue: the opportunities and challenges for therapy using vascular stem/progenitor cells. Stem Cell Res. Ther. 2012, 3:31.
21. Ormiston M.L., Deng Y., Stewart D.J., Courtman D.W. Innate immunity in the therapeutic actions of endothelial progenitor cells in pulmonary hypertension. Am. J. Respir. Cell Mol. Biol. 2010, 43:546-554.
22. Seki T., Yuasa S., Oda M., Egashira T., Yae K., Kusumoto D., Nakata H., Tohyama S., Hashimoto H., Kodaira M., et al. Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells. Cell Stem Cell 2010, 7:11-14.
23. Sun N., Panetta N.J., Gupta D.M., Wilson K.D., Lee A., Jia F., Hu S., Cherry A.M., Robbins R.C., Longaker M.T., et al. Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:15720-15725.
24. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
25. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
26. Thill M., Strunnikova N.V., Berna M.J., Gordiyenko N., Schmid K., Cousins S.W., Thompson D.J., Csaky K.G. Late outgrowth endothelial progenitor cells in patients with age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2008, 49:2696-2708.
27. Walker E., Chang W.Y., Hunkapiller J., Cagney G., Garcha K., Torchia J., Krogan N.J., Reiter J.F., Stanford W.L. Polycomb-like 2 associates with PRC2 and regulates transcriptional networks during mouse embryonic stem cell self-renewal and differentiation. Cell Stem Cell 2010, 6:153-166.